Sort
17,828 grants matching “crispr”
Sterically-Modulated Affinity by RNA Triggers (SMART): a novel toolbox for the purification of CRISPR Cas nucleases
$615,550Stefano Menegatti · North Carolina State University · · FY2025 · ENG
Family Study of Carotid Atherosclerosis and Stroke Risk
$615,412Tatjana Rundek · University Of Miami School Of Medicine · R01 · FY2020 · NS
PARP-1 as a novel target for alpha-particle therapy in high-risk Neuroblastoma
$615,205Daniel A. Pryma · University Of Pennsylvania · R01 · FY2020 · CA
Defining the four major routes of MHC class II antigen processing and presentation with influenza antigens
$614,983Laurence Crane Eisenlohr · Children'S Hosp Of Philadelphia · R01 · FY2024 · AI
Aerosol delivery of combinational therapeutics targeting deadly lung infections
$614,933Qi Zhou · Purdue University · R01 · FY2024 · HL
High-throughput phenotypic screening for functionally characterizing alt. exons
$614,769Thomas Gonatopoulos-Pournatzis · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Investigating the regulation of alternative splicing and its role in disease
$614,769Thomas Gonatopoulos-Pournatzis · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
3/11 Epigenetic Regulation of Neuroimmune Pathways
$614,756Sean P Farris · University Of Pittsburgh At Pittsburgh · U01 · FY2025 · AA
Transcriptome-wide association study to identify susceptibility genes for colorectal cancer
$614,645Xingyi Guo · Vanderbilt University Medical Center · R37 · FY2022 · CA
Binding of Epstein Barr Virus EBNA2 Unifies Multiple Sclerosis Genetic Mechanisms
$614,354Matthew Tyson Weirauch · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · NS
NEI Center Core Grant for Vision Research
$614,337Linda M Zangwill · University Of California, San Diego · P30 · FY2024 · EY
Lentiviral Gene Therapy and Genome Editing for Wiskott-Aldrich Syndrome
$614,320David J Rawlings · St. Jude Children'S Research Hospital · P01 · FY2020 · HL
Characterizing non-coding somatic and germline variant interactions in ovarian cancer
$614,121Simon Andrew Gayther · University Of Texas Hlth Science Center · R01 · FY2024 · CA
NF2-Associated Meningiomas: From Omics Discovery to Targeted Therapy
$613,836Vijaya Ramesh · Massachusetts General Hospital · R01 · FY2024 · NS
Genomic Editing & Screening
$613,727Ralph J. Garippa · Sloan-Kettering Inst Can Research · P30 · FY2025 · CA
Spatiotemporal signaling and trafficking of the mu-opioid receptor
$613,700Ruth Huttenhain · University Of California, San Francisco · R01 · FY2022 · DA
Drug resistance enablers and their role in antibiotic treatment failure
$613,605Vaughn Cooper · Broad Institute, Inc. · U19 · FY2023 · AI
Patient-specific iPSCs to model and treat the inception of pulmonary fibrosis
$613,511Konstantinos Alysandratos · Boston University Medical Campus · P01 · FY2024 · HL
Lmo2-Lyl1 and the bHLH factor network in pro-T cells
$613,350Ellen V. Rothenberg · California Institute Of Technology · R01 · FY2025 · AI
Lmo2-Lyl1 and the bHLH factor network in pro-T cells
$613,350Ellen V. Rothenberg · California Institute Of Technology · R01 · FY2023 · AI
Lmo2-Lyl1 and the bHLH factor network in pro-T cells
$613,350Ellen V. Rothenberg · California Institute Of Technology · R01 · FY2024 · AI
Lmo2-Lyl1 and the bHLH factor network in pro-T cells
$613,350Ellen V. Rothenberg · California Institute Of Technology · R01 · FY2022 · AI
A nucleus-to-mitochondria nucleic acid-sensing pathway prevents bypass of age-associated proliferative boundaries
$613,282Jan Karlseder · Salk Institute For Biological Studies · R01 · FY2024 · AG
A nucleus-to-mitochondria nucleic acid-sensing pathway prevents bypass of age-associated proliferative boundaries
$613,282Jan Karlseder · Salk Institute For Biological Studies · R01 · FY2023 · AG
Identification and characterization of functional genetic variants associated with human longevity
$613,199Jan No Middle Name Vijg · Albert Einstein College Of Medicine · U19 · FY2023 · AG